Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
| abstract | A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with Amyotrophic Lateral Sclerosis (ALS)who have completed the ORARIALS-01 trial. |
| type of project | clinical studies |
| status | aborted |
| start of project | 2019 |
| end of project | 2021 |
| responsible person | Neuwirth, Christoph |